Skip to main content
Clinical Trials/IRCT20200611047727N4
IRCT20200611047727N4
Recruiting
Phase 2

The effectiveness of oxygen delivery through high flow nasal cannula (HFNC) with different temperatures in improving the clinical symptoms of COVID-19 patients

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
30
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • New coronavirus detection (clinical or paraclinical)
  • Oxygen saturation less than 90%
  • Written consent to participate in the study
  • Age over 18 years
  • Moderate to severe Covid\-19 disease is hospitalized and requires respiratory support

Exclusion Criteria

  • Cardiovascular disorders that prevent pulmonary rehabilitation

Outcomes

Primary Outcomes

Not specified

Similar Trials